Financial News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023 at 10:59 AM EDT
Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
